News

Drug Update: Perspective on Two New Alzheimer's Drugs that Have Failed
June 29, 2008
Two new Alzheimer's drugs, Flurizan (Myriad) and Bapineuzumab (Wyeth/Elan), failed clinical trials. Cure Alzheimer's Fund's Dr. Rudy Tanzi offers some...
Read more
Dr. Tanzi to appear on PBS's NOVA scienceNOW, July 2
June 23, 2008
Cure Alzheimer's Fund's Dr. Rudy Tanzi will appear on PBS's NOVA scienceNOW on Wednesday, July 2, to discuss genetic testing and it's impact on Alzheimer's and...
Read more
Dr. Tanzi July 2 interview on PBS's NOVA scienceNOW
June 23, 2008
Cure Alzheimer's Fund's Dr. Rudy Tanzi appeared on PBS's NOVA scienceNOW on Wednesday, July 2, to discuss genetic testing and it's impact on Alzheimer's and...
Read more
Tanzi featured in Los Angeles Times op-ed on Alzheimer's
June 8, 2008
June 8, 2008 Los Angeles Times opinion piece by author and Middlebury scholar Sue Halpern says the years of Alzheimer's research may be paying dividends with...
Read more
More on Tanzi Testimony at Senate Hearing on Alzheimer's
June 7, 2008
Cure Alzheimer's Fund's Dr. Rudy Tanzi's submitted answers to Senator Hillary Rodham Clinton’s questions from the May 14, 2008, Senate Special Committee on...
Read more
A Quick Video Look at Alzheimer's Disease
March 31, 2008
Award winning, national-best selling author David Shenk takes a unique look at Alzheimer’s through a series of four very-short animated films aimed at...
Read more
McCance joins Alzheimer's Study Group to Develop National Strategy dealing with Alzheimer's Disease
December 17, 2007
Cure Alzheimer’s Fund co-founder Henry McCance has been invited to join the Alzheimer’s Study Group (ASG). The private, non-partisan group will be working hard...
Read more
Tomorrow's Leader in Alzheimer's Disease Research Award
November 21, 2007
The Alzheimer’s Association, Cure Alzheimer’s Fund, and the Lou Ruvo Brain Institute award the Tomorrow’s Leader in Alzheimer’s Disease Research prize,...
Read more